University of Missouri
205 Portland Street
Columbia, MO 65211



SPARK is a free online study with a simple mission: to speed up research and advance the understanding of autism. By building a community of tens of thousands of individuals with autism and their biological family members who provide behavioral and genetic data, SPARK will be the largest autism research study to date.

Participation in SPARK can be done entirely at home — register online here.

Find out more about what’s involved on our SPARK page.

Questions? Contact Samantha Hunter at 573-882-6479 or

Early Years Study

The goal of this research study is to learn about how behaviors observed in newborns relate to meeting developmental milestones during the first years of life.

RI-CART Adolescent-Young Adult Study (RAYS)

Brown University researchers are conducting a study examining the challenges and problems that adolescent and young adults experience over the course of adolescence and young adulthood.

  • Eligibility: age 12-24 with ASD and parent/guardian
  • Time required: 4 study visits one year apart for 3 years
  • Location: Online surveys and interviews
  • Monetary Compensation: up to $395 for youth/young adult and up to $225 for parent/guardian
  • Contact: RAYS research team, 401-444-1913,
  • Research study directors: Anthony Spirito, PhD, Stephen Sheinkopf, PhD


The purpose of this study is to validate the ability of a remote eye gaze tracker to differentiate children diagnosed with Autism Spectrum Disorder (ASD) to those with developmental delays. We will also be looking at how well eye gaze correlates with autism symptom severity and language ability.


Participate in a clinical trial exploring the potential effects on social communication and other behaviors.

Biomarker Study

In this study, we want to:

-Gather additional information on subpopulations of autism spectrum disorder as identified by the Sponsor.

-Learn more about autism spectrum disorder by identifying subgroups of patients with autism based on biomarkers. Biomarkers are also known as “biological signs” that can be linked to a condition and how it progresses.

TAPESTRY Clinical Trial (AXL-2004-002)

The purpose of this clinical trial is to explore an investigational drug used to treat irritability symptoms in children and adolescents with autism spectrum disorder.